<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
xmlns:rawvoice="http://www.rawvoice.com/rawvoiceRssModule/"
	>
<channel>
	<title>Comments on: Will This Be The Year For Generic Biologics? Under What Terms?</title>
	<atom:link href="http://www.patentbaristas.com/archives/2009/02/26/will-this-be-the-year-for-generic-biologics-under-what-terms/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2009/02/26/will-this-be-the-year-for-generic-biologics-under-what-terms/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=will-this-be-the-year-for-generic-biologics-under-what-terms</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Tue, 07 Feb 2012 11:57:58 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Antibody Industry Week in Review &#124; 2.27.09 — The Antibody Blog</title>
		<link>http://www.patentbaristas.com/archives/2009/02/26/will-this-be-the-year-for-generic-biologics-under-what-terms/comment-page-1/#comment-65805</link>
		<dc:creator>Antibody Industry Week in Review &#124; 2.27.09 — The Antibody Blog</dc:creator>
		<pubDate>Fri, 27 Feb 2009 11:25:30 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2009/02/26/will-this-be-the-year-for-generic-biologics-under-what-terms/#comment-65805</guid>
		<description>[...] The Obama Administration has signaled support for follow-on biologics.  Patent Baristas provides more commentary. [...]</description>
		<content:encoded><![CDATA[<p>[...] The Obama Administration has signaled support for follow-on biologics.  Patent Baristas provides more commentary. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Mosseri</title>
		<link>http://www.patentbaristas.com/archives/2009/02/26/will-this-be-the-year-for-generic-biologics-under-what-terms/comment-page-1/#comment-65803</link>
		<dc:creator>Chris Mosseri</dc:creator>
		<pubDate>Fri, 27 Feb 2009 11:21:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2009/02/26/will-this-be-the-year-for-generic-biologics-under-what-terms/#comment-65803</guid>
		<description>Confused about the evergreening issue.  If I read it correctly, then would the proposal mean that, say, a pegylated interferon alpha would not be eligible for data exclusivity - even as to the new formulation?  Surely if there is a therapeutic benefit then some incentive to such formulations must be maintained.  Or am I missing something?</description>
		<content:encoded><![CDATA[<p>Confused about the evergreening issue.  If I read it correctly, then would the proposal mean that, say, a pegylated interferon alpha would not be eligible for data exclusivity &#8211; even as to the new formulation?  Surely if there is a therapeutic benefit then some incentive to such formulations must be maintained.  Or am I missing something?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: PWill This Be The Year For Generic Biologics? Under What Terms? &#171; The Stem Cell Blog</title>
		<link>http://www.patentbaristas.com/archives/2009/02/26/will-this-be-the-year-for-generic-biologics-under-what-terms/comment-page-1/#comment-65794</link>
		<dc:creator>PWill This Be The Year For Generic Biologics? Under What Terms? &#171; The Stem Cell Blog</dc:creator>
		<pubDate>Thu, 26 Feb 2009 20:18:00 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2009/02/26/will-this-be-the-year-for-generic-biologics-under-what-terms/#comment-65794</guid>
		<description>[...] Patent Baristas » Will This Be The Year For Generic Biologics? Under What Terms?.    &#9654; Comment   /* 0) { jQuery(&#039;#comments&#039;).show(&#039;&#039;, change_location()); [...]</description>
		<content:encoded><![CDATA[<p>[...] Patent Baristas » Will This Be The Year For Generic Biologics? Under What Terms?.    &#9654; Comment   /* 0) { jQuery(&#8216;#comments&#8217;).show(&#8221;, change_location()); [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: www.patentbaristas.com @ 2012-02-13 00:26:41 -->
